2023 | Secukinumab long-term efficacy and safety in psoriasis through to year 5 of treatment: results of a randomized extension of the phase III ERASURE and FIXTURE trials | Langley, Richard G; Sofen, Howard; Dei-Cas, Ignacio; Reich, Kristian; Sigurgeirsson, Bardur; Warren, Richard B; Paul, Carle; Szepietowski, Jacek C; TSEN-FANG TSAI ; Hampele, Isabelle; You, Ruquan; Charef, Pascal; Papavassilis, Charis | The British journal of dermatology | 6 | | |
2022 | Time to Loss of Response following Withdrawal of Ixekizumab in Patients with Moderate-to-Severe Psoriasis | Papp, Kim; Paul, Carle; Kleyn, C Elise; Huang, Yu-Huei; TSEN-FANG TSAI ; Schuster, Christopher; El Baou, Celine; Toth, Agoston; Riedl, Elisabeth; Mrowietz, Ulrich | Acta dermato-venereologica | 2 | 2 | |